Sino Biopharmaceutical Limited was listed on The Stock Exchange of Hong Kong, a wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited (HKEx), today (Monday). Pictured at the listing ceremony were (from left): Mr Ernest PO, Assistant Vice President, Cash Market Development & Operations, Exchange Business Unit, HKEx; Ms ZHENG Qun, Independent Non-executive Director, Sino Biopharmaceutical Limited; Ms ZHAO Yanping, Vice President; Ms Josephine Price, Non-executive Director; Mr Alex KO, Listing Committee Member, HKEx; Mr TSE Ping, Chairman and President, Sino Biopharmaceutical Limited; Mr TAO Huiqi, Executive Director; Mr ZHANG Baowen, Vice President; Professor GUO Shenggui, Vice President, Ministry of Health, China-Japan Friendship Hospital, P.R. China; Mr Stephen TSE, Vice President, Sino Biopharmaceutical Limited; Mr LING Peixue, Chief Executive Officer, C.P. Freda Pharm Group and Ms Bonnie CHAN, Vice President, Cash Market Development & Operations, Exchange Business Unit, HKEx.

Corporate Communications
8 December 2003

© Copyright 1996-2012 irasia.com Ltd. All rights reserved.

DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website. TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website.